Jeffrey W. Albers - Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
SYRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jeffrey W. Albers since 10/5/2023

Holdings reported by Jeffrey W. Albers for Spyre Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 34.4K $24.4K $0.71 Nov 24, 2023 By Sessions LLC
Stock Option (Right to Buy) 11.3K May 14, 2024 Direct Common Stock
Series A Preferred Stock 0 Nov 24, 2023 By Sessions LLC Common Stock

Transactions reported by Jeffrey W. Albers for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.